Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$15.85 -0.10 (-0.63%)
As of: Oct 2, 2026 · 12:38 PM EDT

Aurinia Pharmaceuticals (AUPH) Return on Assets [ROA] (2021 - 2026)

Updated

Aurinia Pharmaceuticals' Return on Assets [ROA] was 41.43% in Q2 2026, up 29.39 percentage points from 12.04% a year earlier and up 1.01 percentage points from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Aurinia Pharmaceuticals came in at 44.11%, up 43.06 percentage points from FY2024.

  • Return on Assets [ROA] has now increased for four consecutive years, with a five-year change of +70.17 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was 1.05% in FY2024 (+16.36 pp), -15.31% in FY2023 (+6.02 pp), -21.33% in FY2022 (+14.61 pp) and -35.94% in FY2021 (-9.88 pp).
  • Quarterly Return on Assets [ROA] has moved between -41.73% (Q3 2021) and 44.91% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Assets [ROA] has increased for 17 straight quarters, with an average year-over-year change of +23.93 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2025 (a gain of 43.87 percentage points); the worst was Q1 2022 (a drop of 3.16 percentage points).
  • Per Business Quant data, AUPH's Return on Assets [ROA] in the three quarters before Q2 2026 was 40.42% (Q1 2026), 44.91% (Q4 2025) and 15.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Aurinia Pharmaceuticals 2.15 Bn 580.05 Mn 76.67 Mn 41.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.43%
Mar 31, 2026 40.42%
Dec 31, 2025 44.91%
Sep 30, 2025 15.12%
Jun 30, 2025 12.04%
Mar 31, 2025 7.54%
Dec 31, 2024 1.04%
Sep 30, 2024 -4.22%
Jun 30, 2024 -9.69%
Mar 31, 2024 -11.75%
Dec 31, 2023 -14.14%
Sep 30, 2023 -13.99%
Jun 30, 2023 -14.54%
Mar 31, 2023 -20.97%
Dec 31, 2022 -22.56%
Sep 30, 2022 -23.79%
Jun 30, 2022 -31.69%
Mar 31, 2022 -32.03%
Dec 31, 2021 -40.06%
Sep 30, 2021 -41.73%
API Access

Aurinia Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AUPH&period=max&api_key=YOUR_API_KEY